High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$27.2M
$27,163,858
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-03-02 | $1,627,534Largex4 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-02-23 | $1,576,606Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-02-04 | $872,913x2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Coyne Terrance P.
• CFO
10b5-1 SellΔOwn -20.5%
2026-02-03
$4,924,997Largex2
|
||||||
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -20.5%
|
2026-02-03 | $4,924,997Largex2 | S | Form 4 |
|
RPRX
S
Royalty Pharma plc
Coyne Terrance P.
• CFO
10b5-1 SellΔOwn -16.2%
2026-02-02
$4,562,905Largex2
|
||||||
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 SellΔOwn -16.2%
|
2026-02-02 | $4,562,905Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2026-01-20 | $2,737,940Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-12-15 | $2,669,172Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-12-01 | $2,773,956Largex2 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-24 | $2,682,505Largex4 | S | Form 4 |
| RPRX |
Royalty Pharma plc
|
CFO
10b5-1 Sell
|
2025-11-17 | $2,735,329Largex2 | S | Form 4 |